Skip to main content
. 2018 Aug 28;24(32):3583–3616. doi: 10.3748/wjg.v24.i32.3583

Figure 3.

Figure 3

Therapeutic algorithm in unresectable locally advanced, recurrent or metastatic gastric cancer. HER2: Human epidermal growth factor receptor 2; CX: Cisplatin and capecitabine; CF: Cisplatin and fluorouracil; MSI: Microsatellite instability; dMMR: Deficient mismatch repair gene; PD-L1: Programmed death ligand-1.